News/ News/ Sales and Marketing Roche expands COVID testing portfolio with $1.8bn GenMark deal George Underwood diagnostics, GenMark, M&A, molecular testing, Roche, Roche Diagnostics 0 Comment Roche has said it will pay $1.8 billion for molecular testing company GenMark, boosting the Swiss company’s diagnostic Share X Roche expands COVID testing portfolio with $1.8bn GenMark deal https://pharmaphorum.com/news/roche-expands-covid-testing-portfolio-with-1-8bn-genmark-deal/